The latest update is out from Shionogi & Co ( (JP:4507) ).
OSAKA -- Japanese pharmaceutical company Shionogi is working with Nobel laureate Shimon Sakaguchi to develop a cancer ...
TipRanks on MSN
Shionogi Announces Corrections to Q2 2025 Financial Results
The latest update is out from Shionogi & Co ( (JP:4507) ).
SAS Viya Essentials rapidly deploys select SAS Viya products using SAS Managed Cloud Services Thursday, 20 November 2025 - SAS, a global ...
Japanese scientist Shimon Sakaguchi, who was chosen to receive the 2025 Nobel Prize in Physiology or Medicine, and Osaka-based Shionogi & Co. are advancing the development of a new cancer treatment ...
Japanese drugmaker Shionogi has announce the launch of a new formulation of the anti-influenza virus drug Xofluza (baloxavir marboxil) Granules 2%. Xofluza is a first-in-class, single-dose oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback